Structural Models for Roseolovirus U20 And U21: Non-Classical MHC-I Like Proteins From HHV-6A, HHV-6B, and HHV-7.

MHC1b human herpesvirus immune recognition immunoevasion machine learning major histocompatibility protein natural killer cell ligand structure prediction

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 29 01 2022
accepted: 08 03 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 23 4 2022
Statut: epublish

Résumé

Human roseolovirus U20 and U21 are type I membrane glycoproteins that have been implicated in immune evasion by interfering with recognition of classical and non-classical MHC proteins. U20 and U21 are predicted to be type I glycoproteins with extracytosolic immunoglobulin-like domains, but detailed structural information is lacking. AlphaFold and RoseTTAfold are next generation machine-learning-based prediction engines that recently have revolutionized the field of computational three-dimensional protein structure prediction. Here, we review the structural biology of viral immunoevasins and the current status of computational structure prediction algorithms. We use these computational tools to generate structural models for U20 and U21 proteins, which are predicted to adopt MHC-Ia-like folds with closed MHC platforms and immunoglobulin-like domains. We evaluate these structural models and place them within current understanding of the structural basis for viral immune evasion of T cell and natural killer cell recognition.

Identifiants

pubmed: 35444636
doi: 10.3389/fimmu.2022.864898
pmc: PMC9013968
doi:

Substances chimiques

Viral Proteins 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

864898

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI007349
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109858
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI153828
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 Weaver, Arya, Schneider, Hudson and Stern.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):E3578-87
pubmed: 23169621
Science. 2021 Aug 20;373(6557):871-876
pubmed: 34282049
Science. 2022 Feb 4;375(6580):507
pubmed: 35113705
J Virol. 2001 Dec;75(24):12347-58
pubmed: 11711625
Lancet. 1988 May 14;1(8594):1065-7
pubmed: 2896909
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6794-9
pubmed: 11391001
Immunol Rev. 2015 Sep;267(1):137-47
pubmed: 26284475
PLoS Biol. 2012;10(11):e1001432
pubmed: 23209377
Curr Opin Virol. 2014 Dec;9:178-87
pubmed: 25462451
Nat Protoc. 2009;4(3):363-71
pubmed: 19247286
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8826-31
pubmed: 12060703
J Exp Med. 2003 Jun 2;197(11):1427-39
pubmed: 12782710
Virology. 2013 Jul 20;442(1):3-11
pubmed: 23648233
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3131-6
pubmed: 19204290
J Mol Biol. 2000 Jun 2;299(2):499-520
pubmed: 10860755
Curr Opin Immunol. 2021 Jun;70:82-89
pubmed: 33993034
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Acta Paediatr. 1997 Jun;86(6):604-8
pubmed: 9202795
Biol Blood Marrow Transplant. 2012 Jul;18(7):1080-9
pubmed: 22212513
PLoS Pathog. 2011 Nov;7(11):e1002362
pubmed: 22102813
J Biomed Biotechnol. 2011;2011:724607
pubmed: 21765638
Sci Signal. 2017 May 30;10(481):
pubmed: 28559451
Bioinformatics. 1998;14(10):892-3
pubmed: 9927721
J Immunol. 2002 Aug 1;169(3):1395-400
pubmed: 12133964
J Gen Virol. 1976 May;31(2):211-20
pubmed: 932691
N Engl J Med. 2005 Feb 24;352(8):768-76
pubmed: 15728809
J Clin Virol. 2008 Dec;43(4):361-6
pubmed: 18829379
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Proc Int Conf Intell Syst Mol Biol. 1998;6:175-82
pubmed: 9783223
BMC Bioinformatics. 2008 Jan 23;9:40
pubmed: 18215316
Pediatrics. 1994 Jan;93(1):104-8
pubmed: 8265302
Virology. 2009 Apr 10;386(2):462-8
pubmed: 19232662
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5563-8
pubmed: 20212114
PLoS Pathog. 2010 Jan 15;6(1):e1000723
pubmed: 20090832
Immunity. 2001 Dec;15(6):1039-49
pubmed: 11754823
J Biol Chem. 2010 Nov 19;285(47):37016-29
pubmed: 20833720
Curr Biol. 2004 Apr 20;14(8):718-24
pubmed: 15084288
Cell Mol Immunol. 2015 Mar;12(2):139-53
pubmed: 25418469
Immunity. 1999 May;10(5):577-84
pubmed: 10367903
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nature. 1999 Dec 9;402(6762):623-31
pubmed: 10604468
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Traffic. 2003 Dec;4(12):824-37
pubmed: 14617346
Nat Struct Mol Biol. 2021 Nov;28(11):869-870
pubmed: 34716446
J Immunol Methods. 2016 May;432:95-101
pubmed: 26906089
J Virol. 1999 Oct;73(10):8040-52
pubmed: 10482553
J Virol. 2008 Jan;82(2):602-8
pubmed: 17977973
J Cell Sci. 2021 Jun 1;134(11):
pubmed: 34085696
J Virol. 2016 Oct 14;90(21):9608-9617
pubmed: 27535049
Proteins. 2019 Dec;87(12):1141-1148
pubmed: 31602685
Curr Opin Biotechnol. 1999 Dec;10(6):583-8
pubmed: 10600698
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
Eur J Immunol. 2003 Jan;33(1):194-203
pubmed: 12594848
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10095-100
pubmed: 18632577
Annu Rev Immunol. 2013;31:529-61
pubmed: 23298204
J Virol. 2010 Feb;84(3):1265-75
pubmed: 19923186
Nat Immunol. 2003 Dec;4(12):1213-22
pubmed: 14595439
J Immunol. 2011 Feb 1;186(3):1713-22
pubmed: 21187440
J Med Virol. 2001 Nov;65(3):576-83
pubmed: 11596096
Microbiol Immunol. 2015 Jan;59(1):48-53
pubmed: 25346365
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Bioinformatics. 2013 Nov 1;29(21):2722-8
pubmed: 23986568
J Virol. 2009 Aug;83(16):8198-207
pubmed: 19494006
J Biol Chem. 2008 Jun 13;283(24):16840-9
pubmed: 18426793
J Immunol. 2008 Jan 1;180(1):19-24
pubmed: 18096997
J Immunol. 2007 Apr 1;178(7):4473-81
pubmed: 17372005
J Virol. 1996 Sep;70(9):5975-89
pubmed: 8709220
J Virol. 2013 Jan;87(2):840-50
pubmed: 23115291
N Engl J Med. 1994 Aug 18;331(7):432-8
pubmed: 8035839
Nat Immunol. 2013 Jul;14(7):699-705
pubmed: 23666294
Virology. 2007 Aug 15;365(1):125-35
pubmed: 17467766
J Virol. 2010 Apr;84(8):3738-51
pubmed: 20106916
Mol Immunol. 2015 Dec;68(2 Pt A):98-101
pubmed: 25818313
J Virol. 2012 Nov;86(21):11483-92
pubmed: 22896603
Front Immunol. 2021 Oct 15;12:714799
pubmed: 34721381
J Virol. 2014 Mar;88(6):3298-308
pubmed: 24390327
Nat Struct Mol Biol. 2009 Nov;16(11):1189-91
pubmed: 19838188
J Biol Chem. 2007 Nov 30;282(48):35247-58
pubmed: 17897947
mBio. 2021 Feb 16;12(1):
pubmed: 33593967
Biochem Cell Biol. 2017 Jun;95(3):350-358
pubmed: 28314105
EMBO J. 2019 Mar 1;38(5):
pubmed: 30696688
Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G818-28
pubmed: 17082223
Biochemistry. 2010 Apr 13;49(14):3116-28
pubmed: 20199105
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10128-33
pubmed: 17537914
Science. 2018 Dec 7;362(6419):1140-1144
pubmed: 30523106

Auteurs

Grant C Weaver (GC)

Immunology and Microbiology Graduate Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, MA, United States.
Department of Pathology, UMass Chan Medical School, Worcester, MA, United States.

Richa Arya (R)

Department of Pathology, UMass Chan Medical School, Worcester, MA, United States.

Christine L Schneider (CL)

Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI, United States.

Amy W Hudson (AW)

Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI, United States.

Lawrence J Stern (LJ)

Immunology and Microbiology Graduate Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, MA, United States.
Department of Pathology, UMass Chan Medical School, Worcester, MA, United States.
Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH